In-vitro Fertilization Devices are becoming highly popular as they aid patients in convening baby with optimum safety for the couple
The use of in-vitro fertilization to
help treat infertility is a relatively new treatment option for many couples
who struggle to conceive. There have been a number of advances in fertility
treatments over the past several years; however, nothing has yet come close to
the success rate offered by In-vitro Fertilization Devices. For those seeking a
solution to their infertility problems, the use of an In-vitro Fertilization
Device can offer a permanent solution with little effort or risk involved. The
process begins by collecting primary healthy sperm from a male donor, then
inducing the semen into the woman's vagina. Once this is achieved, the In-vitro
Fertilization Device is then used to provide stimulating stimulation to the
uterus and ovaries, resulting in pregnancy.
Although many fertility clinics offer
in-vitro
fertilization devices, the market is not as competitive as many
fertility clinics would like it to be. Many clinics have moved away from
performing IVF's due to the high success rates and extensive medical care
required to maintain the pregnancy once the procedure was performed. Due to
these factors, clinics are often only offering In-vitro fertilization devices
to patients that are undergoing all forms of infertility treatment including
Clomid, IUI, and egg/seminal transfer. However, many patients turn to In-vitro
Fertilization Devices when they no longer wish to take costly fertility
medications and require more personalized treatment options. Some couples
actually prefer the procedure so much that they end up making two separate
fertilization using the same In-vitro Fertilization Device, which allows them
to ensure they receive the maximum chance for conception.
As stated earlier, the first step to
achieve successful fertilization is for the patient to undergo testing to
determine the most favorable time frame to begin In-vitro Fertilization
Therapy. This testing is performed by both a fertility clinic medical staff and
an in-vitro fertilization technician. Once the medical team determines the
ideal time frame to begin therapy, the technicians will then begin harvesting
eggs from the woman's ovaries. Eggs will then be examined under a microscope to
determine the number of chromosomes carried by each egg, this process is known
as the follicle-stimulating factor (FSF). Recently, in July 2018, Merck
launched QBOX IVF and the new Geri Assess 2.0, which enables automatic
detection of key events in embryos.
Comments
Post a Comment